2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells

Blood

Volumn 100, Issue 6, 2002, Pages 2187-2194

  Chauhan, Dharminder ^a   Catley, Laurence ^a   Hideshima, Teru ^a   Li, Guilan ^a   Leblanc, Richard ^a   Gupta, Deepak ^a   Sattler, Martin ^a   Richardson, Paul ^a   Schlossman, Robert L ^a   Podar, Klaus ^a   Weller, Edie ^a   Munshi, Nikhil ^a   Anderson, Kenneth C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; CASPASE 3; CASPASE 8; CASPASE 9; DEXAMETHASONE; DOXORUBICIN; MELPHALAN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW; CELL ADHESION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYMPHOCYTE; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL;

EID: 0037105379     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0376     Document Type: Article

References (46)

1. Synthesis, antitubulin and antimiiotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the coichicine binding site
2. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol
3. Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells
4. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site
5. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol
6. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors
7. 2-Methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells
8. Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas
9. Anti-estrogens induce apoptosis of multiple myeloma cells
10. Estrogen receptors in human myeloma cells
11. Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3
12. 2-Methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells
13. Comparative properties of the catechol estrogens, I: Methylation by catechol-O-methyl-transferase and binding to cytosol estrogen receptors
14. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
15. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma
16. Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
17. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
18. A mechanism of resistance to glucocorticoids in multiple myeloma: Transient expression of a truncated glucocorticoid receptor mRNA
19. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines
20. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin
21. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B
22. Thalidomide and its analogues overcome drug resistance of human multiple myeloma cells to conventional therapy
23. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: Therapeutic applications
24. Cytochrome-c dependent and independent induction of apoptosis in multiple myeloma cells
25. Erasable blot of poly(ADP-ribose) polymerase
26. RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells
27. SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells
28. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
29. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
30. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
31. Inhibition of apoptosis of a PARP(-)/(-)cell line transfected with PARP DNA-binding domain mutants
32. Superoxide dismutase as a target for the selective killing of cancer cells
33. Targeted therapy for multiple myeloma
34. Novel biologically based therapies for myeloma
35. Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma
36. Interleukin-6 prevents dexamethasone-induced myeloma cell death
37. Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan
38. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells
39. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: Synergy through modulation of interleukin-6 autocrine loop at multiple sites
40. Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells
41. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
42. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
43. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c
44. The cell-death machine
45. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
46. 2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: Possible role of vascular endothelial growth factor